Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Mobocertinib
Mobocertinib
1847461-43-1
|
585.697
|
5.632
Mobocertinib is an oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations.
AP-32788 | TAK-788 | mobocertinib
Mobocertinib is an oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations.
AP-32788 | TAK-788 | mobocertinib
$80/5 mg
(EBC)
1
CAS:
0
We provide 0 compound for Mobocertinib